CinRx Pharma is a biopharmaceutical company developing novel therapeutics that address substantial unmet medical needs across diverse disease indications. CinRx does this through partnering (JV, co-developing, direct venture investment) to design and implement critical development activities that will enhance the value of the underlying asset. CinRx’s unique structure and depth of experience allows the Company to act as an operational partner, as well as a capital syndication partner.
The CinRx team has broad expertise in strategic guidance, regulatory planning and submissions, pre-clinical design and implementation, formulation development, CMC, and clinical oversight. In addition, CinRx leverages its relationship with Medpace, Inc, a leading global contract research organization (CRO), to properly engage regulators and efficiently execute clinical stage programs.
- To develop drugs that make a difference to patients' lives
- To challenge the traditional paradigm of decision making and development execution in the pharma industry
- Leverage the extensive accumulated experience of our team to improve the odds of getting innovative and worthy drugs to patients sooner
CinRx has portfolio of promising clinical stage biopharmaceutical assets. These assets have been sourced and capitalized through a variety of partnerships. CinRx is actively looking for late pre-clinical and clinical stage assets targeting indications in cardiovascular and metabolic diseases, CNS, gastroenterology, immunology, rare diseases and oncology.READ MORE